Bristol Myers slashes Revlimid sales projection by $1B, now sees overall revenue decline in 2023
27th July 2023 Uncategorised 0 Bristol Myers slashes Revlimid sales projection by $1B, now sees overall revenue decline in 2023
kdunleavy
Thu, 07/27/2023 – 10:39
More: Bristol Myers slashes Revlimid sales projection by B, now sees overall revenue decline in 2023
Source: fierce